128 related articles for article (PubMed ID: 22923530)
1. Deaths associated with new designer drug 5-IT.
Seetohul LN; Maskell PD; De Paoli G; Pounder DJ
BMJ; 2012 Aug; 345():e5625. PubMed ID: 22923530
[No Abstract] [Full Text] [Related]
2. Delirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT.
Jovel A; Felthous A; Bhattacharyya A
J Forensic Sci; 2014 May; 59(3):844-6. PubMed ID: 24329118
[TBL] [Abstract][Full Text] [Related]
3. Designer drugs as a cause of homicide.
Matsumoto T; Okada T
Addiction; 2006 Nov; 101(11):1666-7. PubMed ID: 17034448
[No Abstract] [Full Text] [Related]
4. [Hallucinogen related mental disorder].
Senoo E
Ryoikibetsu Shokogun Shirizu; 2003; (40):527-9. PubMed ID: 14626176
[No Abstract] [Full Text] [Related]
5. When the designer label equals deadly.
Smith M
Emerg Med Serv; 2002 Sep; 31(9):28, 31. PubMed ID: 12398105
[No Abstract] [Full Text] [Related]
6. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II--piperazines/piperidines, phenylethylamines, tryptamines and miscellaneous 'others'.
Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
Ann Agric Environ Med; 2012; 19(4):871-82. PubMed ID: 23311821
[TBL] [Abstract][Full Text] [Related]
7. Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly.
Corazza O; Schifano F; Farre M; Deluca P; Davey Z; Torrens M; Demetrovics Z; Di Furia L; Flesland L; Siemann H; Skutle A; Van Der Kreeft P; Scherbaum N
Curr Clin Pharmacol; 2011 May; 6(2):125-9. PubMed ID: 21592070
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and Literature Review Based on Related Death and Non-Fatal Case Reports of the Benzofurans and Benzodifurans Designer Drugs.
Barcelo B; Gomila I
Curr Pharm Des; 2017; 23(36):5523-5529. PubMed ID: 28714411
[TBL] [Abstract][Full Text] [Related]
9. New doves, a new legal high?
Herbert J; Tracey JA
Ir Med J; 2010 Mar; 103(3):92-3. PubMed ID: 20666079
[No Abstract] [Full Text] [Related]
10. Deaths linked to synthetic cannabinoids.
Gerostamoulos D; Drummer OH; Woodford NW
Forensic Sci Med Pathol; 2015 Sep; 11(3):478. PubMed ID: 25772119
[No Abstract] [Full Text] [Related]
11. BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
Cohen BM; Butler R
Int J Drug Policy; 2011 Mar; 22(2):95-101. PubMed ID: 21242080
[TBL] [Abstract][Full Text] [Related]
12. Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances.
Ifeagwu SC; Raithelhuber M; Crean C; Gerostamoulos D; Chung H; Tettey JN
Forensic Sci Int; 2017 May; 274():2-6. PubMed ID: 27899215
[TBL] [Abstract][Full Text] [Related]
13. The environmental impact and adverse health effects of the clandestine manufacture of methamphetamine.
Irvine GD; Chin L
NIDA Res Monogr; 1991; 115():33-46. PubMed ID: 1758481
[No Abstract] [Full Text] [Related]
14. Dimethyltryptamine, a do-it-yourself hallucinogenic drug.
Rubin DR
JAMA; 1967 Jul; 201(2):143. PubMed ID: 6072341
[No Abstract] [Full Text] [Related]
15. [New synthesis empathogenic agents].
Velea D; Hautefeuille M; Vazeille G; Lantran-Davoux C
Encephale; 1999; 25(5):508-14. PubMed ID: 10598316
[TBL] [Abstract][Full Text] [Related]
16. Acute confusional state after designer tryptamine abuse.
Itokawa M; Iwata K; Takahashi M; Sugihara G; Sasaki T; Abe Y; Uno M; Hobo M; Jitoku D; Inoue K; Arai M; Yasuda I; Shintani M
Psychiatry Clin Neurosci; 2007 Apr; 61(2):196-9. PubMed ID: 17362440
[TBL] [Abstract][Full Text] [Related]
17. An autopsy case of acetyl fentanyl intoxication caused by insufflation of 'designer drugs'.
Takase I; Koizumi T; Fujimoto I; Yanai A; Fujimiya T
Leg Med (Tokyo); 2016 Jul; 21():38-44. PubMed ID: 27497332
[TBL] [Abstract][Full Text] [Related]
18. Psychoactive tryptamines from basidiomycetes.
Wurst M; Kysilka R; Flieger M
Folia Microbiol (Praha); 2002; 47(1):3-27. PubMed ID: 11980266
[TBL] [Abstract][Full Text] [Related]
19. [MHLW's countermeasures for uncontrolled substance and future tasks].
Yamamoto J
Chudoku Kenkyu; 2004 Jul; 17(3):245-50. PubMed ID: 15495683
[No Abstract] [Full Text] [Related]
20. Designer drugs: a medicinal chemistry perspective.
Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
